Analysis of urinary proteomic patterns for diabetic nephropathy by ProteinChip

Proteomics - Clinical Applications

Volumn 2, Issue 5, 2008, Pages 744-750

  Gu, Wei ^a   Zou, Li Xia ^a   Shan, Peng Fei ^a   Chen, Yi Ding ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Albumin; Diabetic nephropathy; Protein profile; ProteinChip

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CREATININE;

ADULT; AGED; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIAGNOSTIC VALUE; DOWN REGULATION; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION REGULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE PROCEDURE; ONSET AGE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEIN URINE LEVEL; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION;

EID: 44649101940     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780083     Document Type: Article

References (33)

1. Wild, S., Roglic, G.., Green, A., Sicree, R. et al., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27, 1047-1053.
2. Cameron, J. S., The discovery of diabetic nephropathy: from small print to centre stage. J. Nephrol. 2006, 19, S75-S87.
3. Donnelly, R., Wang, B., Qu, X., Type 2 diabetes in China: partnerships in education and research to evaluate new anti-diabetic treatments. Br. J. Clin. Pharmacol. 2006, 61, 702-705.
4. Dong, Y., Gao, W., Nan, H., Yu, H. et al., Prevalence of type 2 diabetes in urban and rural Chinese populations in Qingdao, China. Diabet. Med.2005, 22, 1427-1433.
5. Giunti, S., Barit, D., Cooper, M. E., Diabetic nephropathy: from mechanisms to rational therapies. Minerva Med. 2006, 97, 241-262.
6. Peng, Y. M., Liu, H., Liu, F. Y., Etiologic and relevant tactor analysis of 1,622 ESRD patients with hemodialysis in Hunan province. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006, 31, 400-403.
7. Setffes, M. W., Glomerular lesions of diabetes mellitus: preventable and reversible. Nephrol. Dial. Transplant. 1999, 14, 19-21.
8. Inomat, S., Haneda, M., Moriya, T., Katayama, S. et al., Revised criteria for the early diagnosis of diabetic nephropathy. Nippon Jinzo Gakkai Shi 2005, 47, 767-769.
9. Lin, H. Y., Wang, C. L., Hsiao, P. J., Lu, Y. C. et al., SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes. Diabetes 2007, 56, 1177-1180.
10. Issaq, H. J., Veenstra, T. D., Conrads, T. P., Felschow, D., The SELDI-TOF MS approach to proteamics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 2002, 292, 587-592.
11. Reichelt, O., Muller, J., von Eggeling, F., Driesch, D. et al., Prediction of renal allograft rejection by urinary protein analysis using ProteinChip Arrays (surface-enhanced laser desarption/ionization time-of-flight mass spectrometry). Urology 2006, 67, 472-475.
12. Schaub, S., Wilkins, J., Weiler, T., Sangster, K. et al., Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int. 2004, 65, 323-332.
13. Schaub, S., Wilkins, J. A., Antonovici, M., Krokhin, O. et al., Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am. J. Transplant. 2005, 5, 729-738.
14. Nguyen, M. T., Ross, G.. F., Dent, C. L, Devarajan, P., Early prediction of acute renal injury using urinary proteomics. Am. J. Nephrol. 2005, 25, 318-326.
15. out, H. H., Can, H., Spentzos, D., Nelson, R. G. et al., Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care 2007, 30, 638-643.
16. Wang, J. X., Yu, J. K., Wang, L., Liu. Q. L. et al., Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma. Proteomics 2006, 6, 5344-5349.
17. Mogensen, C. E., Christensen, C. K., Vittinghus, E., The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983, 32 (Suppl 2), 64-78.
18. Vilarrasa, N., Soler, J., Montanya, E., Regression of microalbuminuria in type 1 diabetic patients: results of a sequential intervention with improved metabolic control and ACE inhibitors. Acta Diabetol. 2005, 42, 87-94.
19. Newman, D. J., Mattock, M. B., Dawnay, A. B., Kerry, S. et al., Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol. Assess. 2005, 9, iii-vi, xiii-163.
20. Rai, A. J., Stemmer, P. M., Zhang, Z., Adam, B. L. et al., Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkers. Proteomics 2005, 5, 3467-3474.
21. Chen, Y. D., Zheng, S., Yu, J. K., Hu, X., Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin. Cancer Res. 2004, 10, 8380-8385.
22. Li, Q. Z., Xie, C., Wu, T., Mackay, M. et al., Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J. Clin. Invest. 2005, 115, 3428-3439.
23. Mueller, J., von Eggeling, F., Driesch, D., Schubert, J. et al., ProteinChip technology reveals distinctive protein expression profiles in the urine of bladder cancer patients. Eur. Urol. 2005, 47, 885-894.
24. Zhao, S. Y., Qiao, J., Li, M. Z., Protein expression profilings of polycystic ovary syndrome. Beijing Da Xue Xue Bao 2005, 37, 362-365.
25. Dietze-Schroeder, D., Sell, H., Uhlig, M., Koenen, M. et al., Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. Diabetes 2005, 54, 2003-2011.
26. Quintana, F. J., Hagedorn, P. H., Elizur, G., Merbl, Y. et al., Functional immunomics: microarray analysis of IgG auto-antibody repertoires predicts the future response of mice to induced diabetes. Proc. Natl. Acad. Sci. USA 2004, 101 Suppl 2, 14615-14621.
27. Matthias, M., Thorsten, K., Alena, H., Knueppel, S. et al., Identification of urinary protein pattern in Type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis. J. Diabetes Its Complications 2005, 19, 223-232.
28. Knepper, M. A., Proteomics and the kidney. J. Am. Soc. Nephrol. 2002, 13, 1398-1408.
29. Ewens, K. G., George, R. A., Sharma, K., Ziyadeh. F. N. et al., Assessment of 115 candidate genes for diabetic nephropathy by transmission/disequilibrium test. Diabetes 2005, 54, 3305-3318.
30. Freedman, B. I., Bowden, D. W., Sale, M. M., Langefeld, C. D. et al., Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus. Hypertension 2006, 48, 8-13.
31. William, S. N., What is a support vector machine? Nat. Biotechnol. 2006, 24, 1565-1567.
32. Tao, C. Y., Hoyt, J., Feng, Y., A support vector machine classifier for recognizing mitotic subphases using high-content screening data. J. Biom. Scr. 2007, 12, 490-496.
33. Thomas. S. I., Kulkarni. A. J., Bhaskar. D. et al., A support vector machine-based method for predicting the propensity of a protein to be soluble or to form inclusion body on over-expression in Escherichia coli. Bioinfor. 2006, 22, 278-280.